Sanuwave Health Return on Tangible Equity 2010-2024 | SNWV

Current and historical return on tangible equity values for Sanuwave Health (SNWV) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Sanuwave Health Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2024-09-30 $-0.00B $-0.07B 1.69%
2024-06-30 $-0.00B $-0.05B 6.58%
2024-03-31 $-0.02B $-0.06B 27.17%
2023-12-31 $-0.03B $-0.06B 38.24%
2023-09-30 $-0.05B $-0.08B 74.07%
2023-06-30 $-0.03B $-0.07B 45.57%
2023-03-31 $-0.02B $-0.07B 34.12%
2022-12-31 $-0.01B $-0.05B 20.51%
2022-09-30 $-0.01B $-0.05B 26.80%
2022-06-30 $-0.02B $-0.05B 33.33%
2022-03-31 $-0.03B $-0.05B 58.70%
2021-12-31 $-0.03B $-0.05B 65.85%
2021-09-30 $-0.03B $-0.04B 85.71%
2021-06-30 $-0.04B $-0.04B 121.88%
2021-03-31 $-0.03B $-0.03B 130.77%
2020-12-31 $-0.03B $-0.03B 147.13%
2020-09-30 $-0.02B $-0.03B 133.33%
2020-06-30 $-0.01B $-0.02B 101.96%
2020-03-31 $-0.01B $-0.01B 92.31%
2019-12-31 $-0.01B $-0.01B 80.00%
2019-09-30 $-0.01B $-0.01B 66.67%
2019-06-30 $-0.01B $-0.02B 53.33%
2019-03-31 $-0.01B $-0.02B 54.24%
2018-12-31 $-0.01B $-0.02B 84.21%
2018-09-30 $-0.01B $-0.01B 100.00%
2018-06-30 $-0.01B $-0.02B 108.33%
2018-03-31 $-0.01B $-0.01B 107.32%
2017-12-31 $-0.01B $-0.01B 58.82%
2017-09-30 $-0.00B $-0.01B 51.61%
2017-06-30 $-0.00B $-0.01B 57.14%
2017-03-31 $-0.00B $-0.01B 61.54%
2016-12-31 $-0.01B $-0.01B 96.00%
2016-09-30 $-0.01B $-0.01B 83.33%
2016-06-30 $-0.01B $-0.01B 83.33%
2016-03-31 $-0.01B $-0.01B 104.35%
2015-12-31 $-0.01B $-0.01B 100.00%
2015-09-30 $-0.00B $-0.01B 100.00%
2015-06-30 $-0.00B $-0.01B 145.45%
2015-03-31 $-0.00B $-0.00B 266.67%
2014-12-31 $-0.01B $-0.00B 1200.00%
2014-09-30 $-0.01B $-0.00B 400.00%
2014-06-30 $-0.01B $0.00B 307.69%
2014-03-31 $-0.01B $0.00B 138.46%
2013-12-31 $-0.01B $-0.01B 112.82%
2013-09-30 $-0.01B $-0.01B 120.00%
2013-06-30 $-0.01B $-0.01B 90.00%
2013-03-31 $-0.01B $-0.01B 109.09%
2012-12-31 $-0.01B $-0.01B 92.31%
2012-09-30 $-0.01B $-0.01B 114.29%
2012-06-30 $-0.01B $-0.01B 186.67%
2012-03-31 $-0.01B $-0.01B 444.44%
2011-12-31 $-0.01B $-0.00B 285.71%
2011-09-30 $-0.02B $-0.00B 260.87%
2011-06-30 $-0.02B $0.00B 172.97%
2011-03-31 $-0.02B $-0.01B 120.00%
2010-12-31 $-0.02B $-0.01B 128.00%
2010-09-30 $-0.01B $-0.02B 104.35%
2010-06-30 $-0.01B $-0.01B 129.73%
2010-03-31 $-0.01B $-0.01B 133.33%
2009-12-31 $-0.01B $-0.01B 200.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.173B $0.020B
SANUWAVE Health, Inc. is engaged in the development and commercialization of non-invasive, biological response-activating devices for the repair and regeneration of tissue, musculoskeletal and vascular structures. The Company's product candidates include its proprietary PACE technology applicable in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions; and dermaPACE for treatment of the skin and subcutaneous soft tissue. The Company's products help in activating biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. SANUWAVE Health, Inc. is based in Alpharetta, USA.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $196.653B 25.08
Stryker (SYK) United States $142.804B 32.18
Boston Scientific (BSX) United States $132.807B 38.18
EssilorLuxottica (ESLOY) France $110.936B 0.00
Medtronic (MDT) Ireland $105.763B 15.71
Haleon (HLN) United Kingdom $44.180B 28.71
Lonza Group Ag (LZAGY) Switzerland $43.076B 0.00
GE HealthCare Technologies (GEHC) United States $37.052B 19.22
ResMed (RMD) United States $35.014B 28.77
Terumo (TRUMY) Japan $29.635B 41.85
Koninklijke Philips (PHG) Netherlands $24.241B 18.55
Zimmer Biomet Holdings (ZBH) United States $21.249B 13.53
Insulet (PODD) United States $18.893B 75.23
Baxter (BAX) United States $15.481B 10.07
Smith & Nephew SNATS (SNN) United Kingdom $11.161B 0.00
BellRing Brands (BRBR) United States $10.045B 40.41
Bio-Rad Laboratories (BIO) United States $9.415B 32.00
Demant (WILYY) Denmark $8.300B 0.00
Lantheus Holdings (LNTH) United States $6.467B 15.03
Haemonetics (HAE) United States $4.078B 19.90
Prestige Consumer Healthcare (PBH) United States $4.066B 20.22
ICU Medical (ICUI) United States $3.958B 37.68
Perrigo (PRGO) Ireland $3.745B 11.02
Envista Holdings (NVST) United States $3.351B 24.96
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
GN Store Nord (GNNDY) Denmark $2.928B 18.78
QuidelOrtho (QDEL) United States $2.781B 17.90
Neogen (NEOG) United States $2.633B 30.37
LeMaitre Vascular (LMAT) United States $2.264B 55.02
Green Thumb Industries (GTBIF) United States $1.710B 29.93
AtriCure (ATRC) United States $1.544B 0.00
InMode (INMD) Israel $1.534B 9.22
Maravai LifeSciences Holdings (MRVI) United States $1.432B 0.00
AdaptHealth (AHCO) United States $1.285B 9.18
BioLife Solutions (BLFS) United States $1.239B 0.00
Owens & Minor (OMI) United States $1.075B 8.40
CeriBell (CBLL) United States $1.047B 0.00
Curaleaf Holdings (CURLF) Canada $1.031B 0.00
Phibro Animal Health (PAHC) United States $0.918B 16.19
Evolus (EOLS) United States $0.729B 0.00
VAREX IMAGING (VREX) United States $0.635B 28.07
Capricor Therapeutics (CAPR) United States $0.603B 0.00
Surmodics (SRDX) United States $0.573B 0.00
Cresco Labs (CRLBF) United States $0.488B 0.00
Verano Holdings (VRNOF) United States $0.445B 0.00
Omeros (OMER) United States $0.442B 0.00
Quanterix (QTRX) United States $0.410B 0.00
ZimVie (ZIMV) United States $0.379B 31.93
Biote (BTMD) United States $0.346B 7.58
Viemed Healthcare (VMD) United States $0.340B 32.37
Canopy Growth (CGC) Canada $0.339B 0.00
Valneva SE (VALN) France $0.319B 0.00
Cerus (CERS) United States $0.318B 0.00
Sanara MedTech (SMTI) United States $0.303B 0.00
OraSure Technologies (OSUR) United States $0.292B 19.55
Zynex (ZYXI) United States $0.259B 54.27
High Tide (HITI) Canada $0.257B 106.33
Aurora Cannabis (ACB) Canada $0.236B 0.00
Utah Medical Products (UTMD) United States $0.213B 14.73
MacroGenics (MGNX) United States $0.201B 0.00
Organigram Holdings (OGI) Canada $0.187B 0.00
TerrAscend (TSNDF) Canada $0.176B 0.00
Brainsway (BWAY) Israel $0.157B 94.20
FitLife Brands (FTLF) United States $0.156B 19.65
Quipt Home Medical (QIPT) United States $0.130B 0.00
Jin Medical (ZJYL) China $0.121B 0.00
TriSalus Life Sciences (TLSI) United States $0.119B 0.00
Veru (VERU) United States $0.106B 0.00
Exagen (XGN) United States $0.102B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.100B 0.00
Fonar (FONR) United States $0.098B 11.09
Rockwell Medical (RMTI) United States $0.066B 34.00
Apyx Medical (APYX) United States $0.063B 0.00
InterCure (INCR) Israel $0.060B 0.00
Jushi Holdings (JUSHF) United States $0.056B 0.00
Cytosorbents (CTSO) United States $0.055B 0.00
Modular Medical (MODD) United States $0.055B 0.00
Safety Shot (SHOT) United States $0.050B 0.00
ImmuCell (ICCC) United States $0.044B 0.00
Allurion Technologies (ALUR) United States $0.022B 0.00
Flora Growth (FLGC) United States $0.017B 0.00
Nephros (NEPH) United States $0.016B 0.00
Innovative Eyewear (LUCY) United States $0.015B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Trinity Biotech (TRIB) Ireland $0.007B 0.00
Agape ATP (ATPC) $0.006B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Senestech (SNES) United States $0.004B 0.00
Leafly Holdings (LFLY) United States $0.004B 0.00
Sharps Technology (STSS) United States $0.004B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
GlucoTrack (GCTK) United States $0.001B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 12.93
SNDL (SNDL) Canada $0.000B 0.00